- Home
- DMAC vs ELA Comparison
DMAC vs ELA Comparison
Compare DMAC & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- ELA
- Stock Information
- Founded
- DMAC 2000
- ELA 1965
- Country
- DMAC United States
- ELA United States
- Employees
- DMAC N/A
- ELA N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- ELA Consumer Specialties
- Sector
- DMAC Health Care
- ELA Consumer Discretionary
- Exchange
- DMAC Nasdaq
- ELA Nasdaq
- Market Cap
- DMAC 172.7M
- ELA 162.2M
- IPO Year
- DMAC N/A
- ELA N/A
- Fundamental
- Price
- DMAC $4.18
- ELA $6.47
- Analyst Decision
- DMAC Strong Buy
- ELA Strong Buy
- Analyst Count
- DMAC 3
- ELA 1
- Target Price
- DMAC $7.00
- ELA $7.00
- AVG Volume (30 Days)
- DMAC 46.2K
- ELA 18.0K
- Earning Date
- DMAC 11-13-2024
- ELA 11-05-2024
- Dividend Yield
- DMAC N/A
- ELA N/A
- EPS Growth
- DMAC N/A
- ELA N/A
- EPS
- DMAC N/A
- ELA 0.25
- Revenue
- DMAC N/A
- ELA $165,946,534.00
- Revenue This Year
- DMAC N/A
- ELA N/A
- Revenue Next Year
- DMAC N/A
- ELA $10.07
- P/E Ratio
- DMAC N/A
- ELA $26.48
- Revenue Growth
- DMAC N/A
- ELA N/A
- 52 Week Low
- DMAC $2.14
- ELA $4.00
- 52 Week High
- DMAC $4.95
- ELA $6.50
- Technical
- Relative Strength Index (RSI)
- DMAC 48.23
- ELA 81.85
- Support Level
- DMAC $3.96
- ELA $6.24
- Resistance Level
- DMAC $4.21
- ELA $6.24
- Average True Range (ATR)
- DMAC 0.18
- ELA 0.26
- MACD
- DMAC -0.02
- ELA 0.07
- Stochastic Oscillator
- DMAC 50.00
- ELA 97.46
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About ELA Envela Corporation
Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.